Lidocaine Hydrochloride Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Lidocaine Hydrochloride Market is segmented by Dosage Form (Creams, Injectables, Patches, and Other Dosage Forms), Application (Heart Arrhythmia, Dental Procedure, Epilepsy, and Other Applications), and Geography.

Market Snapshot

lidocaine hydrochloride market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.1 %
lidocaine market

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The lidocaine hydrochloride market size is expected to record a CAGR of 4.1% during the forecast period. An increase in the number of surgical procedures performed across the world, including dental procedures, cosmetic surgeries, and plastic surgeries, is expected to promote growth. The global rise in chronic and acute pain related disorders and various benefits associated with lidocaine hydrochloride are some of the major factors driving the market growth.

A key trend observed in the market is a significant rise in the demand for post-operative pain relief options, on the heels of an increasing number of surgical procedures. This trend is likely to continue to positively influence the demand for lidocaine hydrochloride. As per the study of “Postoperative Pain Control”, around 75% of patients who undergo surgery experience acute postoperative pain, which is often medium-high in severity, which further bolsters the overall growth.

Also, lidocaine patches are available for the treatment of chronic and acute pain. Owing to their safety profile and proven efficacy, lidocaine patches have been recommended as a first-line therapy for the treatment of neuropathic pain in older patients, as well as those suffering from shingles, and this is expected to boost the market growth during the forecast period. However, side effects, such as idiosyncrasy and hypersensitivity, may restrict the market.

Scope of the Report

As per the scope of the report, lidocaine hydrochloride is an anesthetic compound that acts by stabilizing the neuronal membrane by inhibiting ionic fluxes. These are required for the initiation and conduction of nerve impulses, which then perform the local anesthetic action. It is largely utilized as a local anesthetic compound for dental procedures by nerve block or infiltration techniques. The lidocaine hydrochloride market is segmented by dosage form, application, and geography.

By Dosage Form
Other Dosage Forms
By Application
Heart Arrhythmia
Dental Procedure
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Dental Procedure Segment Dominates the Market and is Expected to Continue the Same during the Forecast Period

  • The dental procedure segment is expected to record a lucrative CAGR during the forecast period. This is primarily attributed to the extensive usage of lidocaine hydrochloride injectable in different surgical dental procedures. An increase in the prevalence of dental disorders, coupled with the growing number of surgeries performed, is the key driving factor for this segment.
  • Chronic and acute pain associated with dental procedures is the most common reason for visits to healthcare facilities, which makes it the foremost cause of discomfort in patients, thereby, contributing largely to healthcare costs. The aforementioned factors bode well for the segment's growth.
 lidocaine market size

North America Dominates the Market and is Expected to Continue the Same during the Forecast Period

North America is leading, owing to the presence of major market players. Increasing incidences of pain and pain-related disorders, coupled with the escalating prevalence of epilepsy and dental procedures in the United States, are among the factors driving the market in this region. This has been adding to the healthcare expenditures of the nations in the region. The incremental rise in the number of patients and increasing product cognizance and adoption have also been accelerating market growth in the region.

Asia-Pacific is expected to witness the fastest growth over the forecast period. The growth is attributed to the increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of lidocaine hydrochloride in post-operative pain management. Moreover, the expanding geriatric population is anticipated to drive the number of surgical procedures performed in the region, thereby promising growth over the forecast period.

 lidocaine market share

Competitive Landscape

The lidocaine hydrochloride market is consolidated and consists of a selective number of major players. Some of the key players include companies, such as Alanza Inc, Amphastar Pharmaceuticals, Inc., Cirondrugs, Mahendra Chemicals, Medexim India, Merck KGaA, Nortec Qumica, and Pfizer Inc. Investment for the development of effective and long-acting products with lesser adverse effects and improving geographical penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market shares.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Prevalence of Target Diseases

      2. 4.2.2 Rising Demand for Anesthetics in Surgeries

    3. 4.3 Market Restraints

      1. 4.3.1 Risk Associated with Lidocaine Hydrochloride

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Dosage Form

      1. 5.1.1 Creams

      2. 5.1.2 Patches

      3. 5.1.3 Injectables

      4. 5.1.4 Other Dosage Forms

    2. 5.2 By Application

      1. 5.2.1 Heart Arrhythmia

      2. 5.2.2 Dental Procedure

      3. 5.2.3 Epilepsy

      4. 5.2.4 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Alanza Inc

      2. 6.1.2 Amphastar Pharmaceuticals Inc.

      3. 6.1.3 Cirondrugs

      4. 6.1.4 Mahendra Chemicals

      5. 6.1.5 Medexim India

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Nortec Qumica

      8. 6.1.8 Pfizer Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Lidocaine Hydrochloride Market market is studied from 2018 - 2026.

The Lidocaine Hydrochloride Market is growing at a CAGR of 4.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Pfizer Inc , Merck KGaA , MAHENDRA CHEMICALS , Nortec Qumica, Cirondrugs are the major companies operating in Lidocaine Hydrochloride Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!